We are almost there ...
MedPlus is in a funk. Can Reddy’s private-label push revive it?
India’s only listed pharma retailer wants to rev up growth by boosting its own-brand business. But will it be enough to overcome its mounting debt, slowing revenue growth and a stalled fundraise?
03 July, 2024•11 min
0
03 July, 2024•11 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
SUBSCRIBE
Already have an account? Sign In
More in Business
Business
IndiGo’s Rahul Bhatia may have another winner—in hospitality
The partnership between his InterGlobe Hotels and French multinational Accor poses a serious challenge to the leadership of Tata’s IHCL and American multinational Marriott in the hospitality business.
You may also like
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Business
How Glenmark convinced its investors to back its high-risk R&D strategy
While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.
Business
Carrefour exits from two key Middle East markets
The firm that played a pivotal role in introducing the French hypermarket to the Arab world is having to course-correct in response to geopolitical concerns in the region.
